It has an efficacy of 50.7%
A fifth COVID-19 vaccine has been approved in Pakistan: China’s Sinovac shot called CoronaVac. It has an efficacy of 50.7%. The country also awaits supplies of the Astrazeneca vaccine through COVAX. This shot has been surrounded by controversy because of reports of blood clots after vaccination. Watch this video to find out more.